23 Sep 2011 | 01:01 pm |
International law firm Pinsent Masons has been named Private Equity Law Firm of the Year in the 2011 Unquote British Private Equity Awards.
International law firm Pinsent Masons has been named Private Equity Law Firm of the Year in the 2011 Unquote British Private Equity Awards.
The awards are widely recognised as the leading private equity awards in the UK. The judges praised Pinsent Masons for its focus and determination to build and develop long lasting institutional relationships in the mid market. This focus has seen the firm advise institutions including ECI, BPE, HIG, and ISIS on a number of high profile deals during the year.
In addition the international private equity practice of Pinsent Masons has advised on a number of complex cross border transactions, particularly in the Far East where the firm advised on the US$700 million buyout of Hyva Group from 3i.
Gregg Davison, Pinsent Masons commented: "The success of any law firm is down to the strength and quality of its clients. We are delighted that even in these challenging times, our institutional clients remain focussed on doing deals. We thank them for their continued support and for choosing Pinsent Masons to be part of their team both in the UK and globally. "
Unquote is a leading European private equity information service which has been researching markets for over twenty years.
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]